nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS2—urinary bladder cancer	0.474	1	CbGaD
Tenoxicam—PTGS2—Cisplatin—urinary bladder cancer	0.0734	0.236	CbGbCtD
Tenoxicam—PTGS2—Etoposide—urinary bladder cancer	0.0721	0.232	CbGbCtD
Tenoxicam—PTGS1—Etoposide—urinary bladder cancer	0.0609	0.196	CbGbCtD
Tenoxicam—SLC22A8—Methotrexate—urinary bladder cancer	0.0506	0.163	CbGbCtD
Tenoxicam—CYP2C9—Fluorouracil—urinary bladder cancer	0.0294	0.0943	CbGbCtD
Tenoxicam—CYP2C9—Cisplatin—urinary bladder cancer	0.0249	0.0801	CbGbCtD
Tenoxicam—SLC22A8—urine—urinary bladder cancer	0.00546	0.211	CbGeAlD
Tenoxicam—CYP2C9—urine—urinary bladder cancer	0.00355	0.137	CbGeAlD
Tenoxicam—SLC22A8—prostate gland—urinary bladder cancer	0.00196	0.0758	CbGeAlD
Tenoxicam—Lornoxicam—PTGS2—urinary bladder cancer	0.00177	0.457	CrCbGaD
Tenoxicam—SLC22A8—renal system—urinary bladder cancer	0.00134	0.0517	CbGeAlD
Tenoxicam—PTGS1—prostate gland—urinary bladder cancer	0.00116	0.045	CbGeAlD
Tenoxicam—Meloxicam—PTGS2—urinary bladder cancer	0.00112	0.291	CrCbGaD
Tenoxicam—PTGS2—prostate gland—urinary bladder cancer	0.00111	0.043	CbGeAlD
Tenoxicam—PTGS1—seminal vesicle—urinary bladder cancer	0.000985	0.038	CbGeAlD
Tenoxicam—Piroxicam—PTGS2—urinary bladder cancer	0.000975	0.252	CrCbGaD
Tenoxicam—PTGS2—seminal vesicle—urinary bladder cancer	0.000941	0.0364	CbGeAlD
Tenoxicam—PTGS1—epithelium—urinary bladder cancer	0.000855	0.033	CbGeAlD
Tenoxicam—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000824	0.0318	CbGeAlD
Tenoxicam—PTGS2—epithelium—urinary bladder cancer	0.000818	0.0316	CbGeAlD
Tenoxicam—PTGS1—renal system—urinary bladder cancer	0.000793	0.0307	CbGeAlD
Tenoxicam—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000788	0.0304	CbGeAlD
Tenoxicam—PTGS2—renal system—urinary bladder cancer	0.000758	0.0293	CbGeAlD
Tenoxicam—PTGS2—urethra—urinary bladder cancer	0.000745	0.0288	CbGeAlD
Tenoxicam—CYP2C9—female reproductive system—urinary bladder cancer	0.000696	0.0269	CbGeAlD
Tenoxicam—PTGS1—female reproductive system—urinary bladder cancer	0.000635	0.0245	CbGeAlD
Tenoxicam—PTGS2—female reproductive system—urinary bladder cancer	0.000607	0.0235	CbGeAlD
Tenoxicam—PTGS1—vagina—urinary bladder cancer	0.000575	0.0222	CbGeAlD
Tenoxicam—PTGS2—vagina—urinary bladder cancer	0.000549	0.0212	CbGeAlD
Tenoxicam—PTGS1—lymph node—urinary bladder cancer	0.000372	0.0144	CbGeAlD
Tenoxicam—Immune system disorder—Etoposide—urinary bladder cancer	0.000364	0.00244	CcSEcCtD
Tenoxicam—Leukopenia—Fluorouracil—urinary bladder cancer	0.000362	0.00242	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000357	0.00996	CbGpPWpGaD
Tenoxicam—PTGS2—lymph node—urinary bladder cancer	0.000355	0.0137	CbGeAlD
Tenoxicam—Anaemia—Cisplatin—urinary bladder cancer	0.000354	0.00237	CcSEcCtD
Tenoxicam—Dyspepsia—Thiotepa—urinary bladder cancer	0.000351	0.00235	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000347	0.00233	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.000347	0.00968	CbGpPWpGaD
Tenoxicam—Decreased appetite—Thiotepa—urinary bladder cancer	0.000347	0.00232	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000344	0.0023	CcSEcCtD
Tenoxicam—Fatigue—Thiotepa—urinary bladder cancer	0.000344	0.0023	CcSEcCtD
Tenoxicam—Leukopenia—Cisplatin—urinary bladder cancer	0.000343	0.00229	CcSEcCtD
Tenoxicam—Constipation—Thiotepa—urinary bladder cancer	0.000341	0.00228	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000337	0.00939	CbGpPWpGaD
Tenoxicam—Oedema—Gemcitabine—urinary bladder cancer	0.000335	0.00224	CcSEcCtD
Tenoxicam—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000335	0.00224	CcSEcCtD
Tenoxicam—Cardiac failure—Epirubicin—urinary bladder cancer	0.000335	0.00224	CcSEcCtD
Tenoxicam—Oedema—Fluorouracil—urinary bladder cancer	0.00033	0.00221	CcSEcCtD
Tenoxicam—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00033	0.00221	CcSEcCtD
Tenoxicam—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000329	0.0022	CcSEcCtD
Tenoxicam—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000328	0.0022	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000327	0.00219	CcSEcCtD
Tenoxicam—Skin disorder—Gemcitabine—urinary bladder cancer	0.000326	0.00218	CcSEcCtD
Tenoxicam—Anaemia—Etoposide—urinary bladder cancer	0.000324	0.00217	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000324	0.00217	CcSEcCtD
Tenoxicam—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000323	0.00216	CcSEcCtD
Tenoxicam—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000323	0.00216	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000322	0.00897	CbGpPWpGaD
Tenoxicam—Anorexia—Gemcitabine—urinary bladder cancer	0.00032	0.00214	CcSEcCtD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000318	0.00888	CbGpPWpGaD
Tenoxicam—CYP2C9—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000317	0.00884	CbGpPWpGaD
Tenoxicam—Urticaria—Thiotepa—urinary bladder cancer	0.000317	0.00212	CcSEcCtD
Tenoxicam—Breast disorder—Methotrexate—urinary bladder cancer	0.000315	0.00211	CcSEcCtD
Tenoxicam—Vertigo—Etoposide—urinary bladder cancer	0.000315	0.00211	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000314	0.00877	CbGpPWpGaD
Tenoxicam—Anorexia—Fluorouracil—urinary bladder cancer	0.000314	0.0021	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000314	0.0021	CcSEcCtD
Tenoxicam—Leukopenia—Etoposide—urinary bladder cancer	0.000314	0.0021	CcSEcCtD
Tenoxicam—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000313	0.00209	CcSEcCtD
Tenoxicam—Oedema—Cisplatin—urinary bladder cancer	0.000313	0.00209	CcSEcCtD
Tenoxicam—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00031	0.00207	CcSEcCtD
Tenoxicam—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000307	0.00205	CcSEcCtD
Tenoxicam—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000306	0.00205	CcSEcCtD
Tenoxicam—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.000304	0.00849	CbGpPWpGaD
Tenoxicam—Skin disorder—Cisplatin—urinary bladder cancer	0.000304	0.00203	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000302	0.00202	CcSEcCtD
Tenoxicam—Asthma—Methotrexate—urinary bladder cancer	0.000302	0.00202	CcSEcCtD
Tenoxicam—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000299	0.002	CcSEcCtD
Tenoxicam—Anorexia—Cisplatin—urinary bladder cancer	0.000298	0.00199	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000297	0.00199	CcSEcCtD
Tenoxicam—Breast disorder—Epirubicin—urinary bladder cancer	0.000295	0.00198	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000294	0.00197	CcSEcCtD
Tenoxicam—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000294	0.00197	CcSEcCtD
Tenoxicam—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000294	0.00197	CcSEcCtD
Tenoxicam—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000291	0.00195	CcSEcCtD
Tenoxicam—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00029	0.00194	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000289	0.00194	CcSEcCtD
Tenoxicam—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000289	0.00194	CcSEcCtD
Tenoxicam—Fatigue—Gemcitabine—urinary bladder cancer	0.000289	0.00194	CcSEcCtD
Tenoxicam—Gastritis—Epirubicin—urinary bladder cancer	0.000289	0.00193	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000289	0.00805	CbGpPWpGaD
Tenoxicam—PTGS1—Eicosanoid Synthesis—PTGS2—urinary bladder cancer	0.000288	0.00803	CbGpPWpGaD
Tenoxicam—Constipation—Gemcitabine—urinary bladder cancer	0.000287	0.00192	CcSEcCtD
Tenoxicam—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000287	0.00192	CcSEcCtD
Tenoxicam—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000286	0.00192	CcSEcCtD
Tenoxicam—Asthenia—Thiotepa—urinary bladder cancer	0.000286	0.00191	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000285	0.00191	CcSEcCtD
Tenoxicam—Asthma—Epirubicin—urinary bladder cancer	0.000282	0.00189	CcSEcCtD
Tenoxicam—Pruritus—Thiotepa—urinary bladder cancer	0.000282	0.00189	CcSEcCtD
Tenoxicam—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00028	0.00188	CcSEcCtD
Tenoxicam—Dyspnoea—Cisplatin—urinary bladder cancer	0.000279	0.00187	CcSEcCtD
Tenoxicam—Skin disorder—Etoposide—urinary bladder cancer	0.000278	0.00186	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000278	0.00776	CbGpPWpGaD
Tenoxicam—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000275	0.00184	CcSEcCtD
Tenoxicam—Breast disorder—Doxorubicin—urinary bladder cancer	0.000273	0.00183	CcSEcCtD
Tenoxicam—Anorexia—Etoposide—urinary bladder cancer	0.000273	0.00183	CcSEcCtD
Tenoxicam—Diarrhoea—Thiotepa—urinary bladder cancer	0.000273	0.00183	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000272	0.00182	CcSEcCtD
Tenoxicam—PTGS1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000272	0.00758	CbGpPWpGaD
Tenoxicam—Decreased appetite—Cisplatin—urinary bladder cancer	0.000272	0.00182	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00027	0.00181	CcSEcCtD
Tenoxicam—Gastritis—Doxorubicin—urinary bladder cancer	0.000267	0.00179	CcSEcCtD
Tenoxicam—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000267	0.00745	CbGpPWpGaD
Tenoxicam—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000267	0.00178	CcSEcCtD
Tenoxicam—Dizziness—Thiotepa—urinary bladder cancer	0.000264	0.00176	CcSEcCtD
Tenoxicam—Stomatitis—Methotrexate—urinary bladder cancer	0.000262	0.00175	CcSEcCtD
Tenoxicam—Urticaria—Fluorouracil—urinary bladder cancer	0.000262	0.00175	CcSEcCtD
Tenoxicam—Asthma—Doxorubicin—urinary bladder cancer	0.000261	0.00175	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000258	0.00172	CcSEcCtD
Tenoxicam—Dyspnoea—Etoposide—urinary bladder cancer	0.000255	0.00171	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000254	0.0017	CcSEcCtD
Tenoxicam—Vomiting—Thiotepa—urinary bladder cancer	0.000253	0.0017	CcSEcCtD
Tenoxicam—Rash—Thiotepa—urinary bladder cancer	0.000251	0.00168	CcSEcCtD
Tenoxicam—Dermatitis—Thiotepa—urinary bladder cancer	0.000251	0.00168	CcSEcCtD
Tenoxicam—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000251	0.00168	CcSEcCtD
Tenoxicam—Headache—Thiotepa—urinary bladder cancer	0.00025	0.00167	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000249	0.00167	CcSEcCtD
Tenoxicam—Decreased appetite—Etoposide—urinary bladder cancer	0.000249	0.00167	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000247	0.00165	CcSEcCtD
Tenoxicam—Fatigue—Etoposide—urinary bladder cancer	0.000247	0.00165	CcSEcCtD
Tenoxicam—Stomatitis—Epirubicin—urinary bladder cancer	0.000245	0.00164	CcSEcCtD
Tenoxicam—Constipation—Etoposide—urinary bladder cancer	0.000245	0.00164	CcSEcCtD
Tenoxicam—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000243	0.00163	CcSEcCtD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000242	0.00674	CbGpPWpGaD
Tenoxicam—Hepatitis—Methotrexate—urinary bladder cancer	0.000241	0.00162	CcSEcCtD
Tenoxicam—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.000241	0.00672	CbGpPWpGaD
Tenoxicam—Asthenia—Gemcitabine—urinary bladder cancer	0.000241	0.00161	CcSEcCtD
Tenoxicam—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000238	0.0016	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000238	0.0016	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000238	0.00159	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000238	0.00664	CbGpPWpGaD
Tenoxicam—Pruritus—Gemcitabine—urinary bladder cancer	0.000237	0.00159	CcSEcCtD
Tenoxicam—Nausea—Thiotepa—urinary bladder cancer	0.000237	0.00159	CcSEcCtD
Tenoxicam—Urethral disorder—Methotrexate—urinary bladder cancer	0.000237	0.00158	CcSEcCtD
Tenoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000236	0.00657	CbGpPWpGaD
Tenoxicam—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000235	0.00157	CcSEcCtD
Tenoxicam—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000234	0.00654	CbGpPWpGaD
Tenoxicam—Pruritus—Fluorouracil—urinary bladder cancer	0.000233	0.00156	CcSEcCtD
Tenoxicam—Visual impairment—Methotrexate—urinary bladder cancer	0.000233	0.00156	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000231	0.00155	CcSEcCtD
Tenoxicam—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00023	0.00154	CcSEcCtD
Tenoxicam—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000229	0.00154	CcSEcCtD
Tenoxicam—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000229	0.00639	CbGpPWpGaD
Tenoxicam—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000228	0.00153	CcSEcCtD
Tenoxicam—Urticaria—Etoposide—urinary bladder cancer	0.000227	0.00152	CcSEcCtD
Tenoxicam—Stomatitis—Doxorubicin—urinary bladder cancer	0.000227	0.00152	CcSEcCtD
Tenoxicam—Hepatitis—Epirubicin—urinary bladder cancer	0.000226	0.00151	CcSEcCtD
Tenoxicam—Eye disorder—Methotrexate—urinary bladder cancer	0.000226	0.00151	CcSEcCtD
Tenoxicam—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000226	0.00151	CcSEcCtD
Tenoxicam—Asthenia—Cisplatin—urinary bladder cancer	0.000224	0.0015	CcSEcCtD
Tenoxicam—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000224	0.0015	CcSEcCtD
Tenoxicam—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000223	0.00149	CcSEcCtD
Tenoxicam—Urethral disorder—Epirubicin—urinary bladder cancer	0.000221	0.00148	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00022	0.00147	CcSEcCtD
Tenoxicam—Angiopathy—Methotrexate—urinary bladder cancer	0.000219	0.00147	CcSEcCtD
Tenoxicam—Immune system disorder—Methotrexate—urinary bladder cancer	0.000218	0.00146	CcSEcCtD
Tenoxicam—Dizziness—Fluorouracil—urinary bladder cancer	0.000218	0.00146	CcSEcCtD
Tenoxicam—Visual impairment—Epirubicin—urinary bladder cancer	0.000218	0.00146	CcSEcCtD
Tenoxicam—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000217	0.00145	CcSEcCtD
Tenoxicam—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.000217	0.00604	CbGpPWpGaD
Tenoxicam—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000216	0.00602	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000214	0.00597	CbGpPWpGaD
Tenoxicam—Diarrhoea—Cisplatin—urinary bladder cancer	0.000214	0.00143	CcSEcCtD
Tenoxicam—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000214	0.00143	CcSEcCtD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000214	0.00596	CbGpPWpGaD
Tenoxicam—Vomiting—Gemcitabine—urinary bladder cancer	0.000213	0.00143	CcSEcCtD
Tenoxicam—Mental disorder—Methotrexate—urinary bladder cancer	0.000211	0.00142	CcSEcCtD
Tenoxicam—Rash—Gemcitabine—urinary bladder cancer	0.000211	0.00142	CcSEcCtD
Tenoxicam—Dermatitis—Gemcitabine—urinary bladder cancer	0.000211	0.00141	CcSEcCtD
Tenoxicam—Eye disorder—Epirubicin—urinary bladder cancer	0.000211	0.00141	CcSEcCtD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000211	0.00589	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Etoposide—urinary bladder cancer	0.000211	0.00141	CcSEcCtD
Tenoxicam—Erythema—Methotrexate—urinary bladder cancer	0.00021	0.00141	CcSEcCtD
Tenoxicam—Malnutrition—Methotrexate—urinary bladder cancer	0.00021	0.00141	CcSEcCtD
Tenoxicam—Headache—Gemcitabine—urinary bladder cancer	0.00021	0.00141	CcSEcCtD
Tenoxicam—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00021	0.0014	CcSEcCtD
Tenoxicam—Vomiting—Fluorouracil—urinary bladder cancer	0.00021	0.0014	CcSEcCtD
Tenoxicam—Hepatitis—Doxorubicin—urinary bladder cancer	0.000209	0.0014	CcSEcCtD
Tenoxicam—Rash—Fluorouracil—urinary bladder cancer	0.000208	0.00139	CcSEcCtD
Tenoxicam—Dermatitis—Fluorouracil—urinary bladder cancer	0.000208	0.00139	CcSEcCtD
Tenoxicam—Headache—Fluorouracil—urinary bladder cancer	0.000207	0.00138	CcSEcCtD
Tenoxicam—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000206	0.00138	CcSEcCtD
Tenoxicam—Asthenia—Etoposide—urinary bladder cancer	0.000205	0.00138	CcSEcCtD
Tenoxicam—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.000205	0.00573	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.000205	0.00573	CbGpPWpGaD
Tenoxicam—Angiopathy—Epirubicin—urinary bladder cancer	0.000205	0.00137	CcSEcCtD
Tenoxicam—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000205	0.00137	CcSEcCtD
Tenoxicam—Immune system disorder—Epirubicin—urinary bladder cancer	0.000204	0.00137	CcSEcCtD
Tenoxicam—Pruritus—Etoposide—urinary bladder cancer	0.000203	0.00136	CcSEcCtD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000202	0.00565	CbGpPWpGaD
Tenoxicam—Visual impairment—Doxorubicin—urinary bladder cancer	0.000201	0.00135	CcSEcCtD
Tenoxicam—Nausea—Gemcitabine—urinary bladder cancer	0.000199	0.00133	CcSEcCtD
Tenoxicam—Vomiting—Cisplatin—urinary bladder cancer	0.000199	0.00133	CcSEcCtD
Tenoxicam—Mental disorder—Epirubicin—urinary bladder cancer	0.000198	0.00133	CcSEcCtD
Tenoxicam—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000198	0.00132	CcSEcCtD
Tenoxicam—Rash—Cisplatin—urinary bladder cancer	0.000197	0.00132	CcSEcCtD
Tenoxicam—Dermatitis—Cisplatin—urinary bladder cancer	0.000197	0.00132	CcSEcCtD
Tenoxicam—Erythema—Epirubicin—urinary bladder cancer	0.000197	0.00132	CcSEcCtD
Tenoxicam—Malnutrition—Epirubicin—urinary bladder cancer	0.000197	0.00132	CcSEcCtD
Tenoxicam—Diarrhoea—Etoposide—urinary bladder cancer	0.000196	0.00131	CcSEcCtD
Tenoxicam—Nausea—Fluorouracil—urinary bladder cancer	0.000196	0.00131	CcSEcCtD
Tenoxicam—Eye disorder—Doxorubicin—urinary bladder cancer	0.000195	0.00131	CcSEcCtD
Tenoxicam—Anaemia—Methotrexate—urinary bladder cancer	0.000194	0.0013	CcSEcCtD
Tenoxicam—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000194	0.0013	CcSEcCtD
Tenoxicam—Angiopathy—Doxorubicin—urinary bladder cancer	0.00019	0.00127	CcSEcCtD
Tenoxicam—Dizziness—Etoposide—urinary bladder cancer	0.000189	0.00127	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000189	0.00528	CbGpPWpGaD
Tenoxicam—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000189	0.00126	CcSEcCtD
Tenoxicam—Vertigo—Methotrexate—urinary bladder cancer	0.000189	0.00126	CcSEcCtD
Tenoxicam—Leukopenia—Methotrexate—urinary bladder cancer	0.000188	0.00126	CcSEcCtD
Tenoxicam—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.000188	0.00524	CbGpPWpGaD
Tenoxicam—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000186	0.00519	CbGpPWpGaD
Tenoxicam—Nausea—Cisplatin—urinary bladder cancer	0.000186	0.00124	CcSEcCtD
Tenoxicam—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000185	0.00516	CbGpPWpGaD
Tenoxicam—Mental disorder—Doxorubicin—urinary bladder cancer	0.000183	0.00123	CcSEcCtD
Tenoxicam—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000182	0.00508	CbGpPWpGaD
Tenoxicam—Vomiting—Etoposide—urinary bladder cancer	0.000182	0.00122	CcSEcCtD
Tenoxicam—Erythema—Doxorubicin—urinary bladder cancer	0.000182	0.00122	CcSEcCtD
Tenoxicam—Malnutrition—Doxorubicin—urinary bladder cancer	0.000182	0.00122	CcSEcCtD
Tenoxicam—Anaemia—Epirubicin—urinary bladder cancer	0.000182	0.00122	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000181	0.00506	CbGpPWpGaD
Tenoxicam—Rash—Etoposide—urinary bladder cancer	0.000181	0.00121	CcSEcCtD
Tenoxicam—Dermatitis—Etoposide—urinary bladder cancer	0.00018	0.00121	CcSEcCtD
Tenoxicam—Headache—Etoposide—urinary bladder cancer	0.000179	0.0012	CcSEcCtD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000178	0.00496	CbGpPWpGaD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000178	0.00119	CcSEcCtD
Tenoxicam—Vertigo—Epirubicin—urinary bladder cancer	0.000177	0.00118	CcSEcCtD
Tenoxicam—Leukopenia—Epirubicin—urinary bladder cancer	0.000176	0.00118	CcSEcCtD
Tenoxicam—Palpitations—Epirubicin—urinary bladder cancer	0.000174	0.00116	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000173	0.00482	CbGpPWpGaD
Tenoxicam—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000172	0.00115	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.000171	0.00477	CbGpPWpGaD
Tenoxicam—Nausea—Etoposide—urinary bladder cancer	0.00017	0.00114	CcSEcCtD
Tenoxicam—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000169	0.00472	CbGpPWpGaD
Tenoxicam—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000168	0.00113	CcSEcCtD
Tenoxicam—Anaemia—Doxorubicin—urinary bladder cancer	0.000168	0.00113	CcSEcCtD
Tenoxicam—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000168	0.00112	CcSEcCtD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000167	0.00465	CbGpPWpGaD
Tenoxicam—Skin disorder—Methotrexate—urinary bladder cancer	0.000167	0.00112	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000166	0.00111	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000166	0.00463	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000165	0.00461	CbGpPWpGaD
Tenoxicam—Dry mouth—Epirubicin—urinary bladder cancer	0.000164	0.0011	CcSEcCtD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000164	0.00457	CbGpPWpGaD
Tenoxicam—Vertigo—Doxorubicin—urinary bladder cancer	0.000163	0.00109	CcSEcCtD
Tenoxicam—Anorexia—Methotrexate—urinary bladder cancer	0.000163	0.00109	CcSEcCtD
Tenoxicam—Leukopenia—Doxorubicin—urinary bladder cancer	0.000163	0.00109	CcSEcCtD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000162	0.00451	CbGpPWpGaD
Tenoxicam—Palpitations—Doxorubicin—urinary bladder cancer	0.000161	0.00108	CcSEcCtD
Tenoxicam—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000161	0.00107	CcSEcCtD
Tenoxicam—Oedema—Epirubicin—urinary bladder cancer	0.000161	0.00107	CcSEcCtD
Tenoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00016	0.00446	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00016	0.00445	CbGpPWpGaD
Tenoxicam—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000157	0.00105	CcSEcCtD
Tenoxicam—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000157	0.00105	CcSEcCtD
Tenoxicam—Skin disorder—Epirubicin—urinary bladder cancer	0.000156	0.00104	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000154	0.00103	CcSEcCtD
Tenoxicam—Anorexia—Epirubicin—urinary bladder cancer	0.000153	0.00102	CcSEcCtD
Tenoxicam—Dyspnoea—Methotrexate—urinary bladder cancer	0.000153	0.00102	CcSEcCtD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000153	0.00426	CbGpPWpGaD
Tenoxicam—Dry mouth—Doxorubicin—urinary bladder cancer	0.000152	0.00101	CcSEcCtD
Tenoxicam—Dyspepsia—Methotrexate—urinary bladder cancer	0.000151	0.00101	CcSEcCtD
Tenoxicam—Decreased appetite—Methotrexate—urinary bladder cancer	0.000149	0.000998	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000149	0.00415	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000149	0.00415	CbGpPWpGaD
Tenoxicam—Oedema—Doxorubicin—urinary bladder cancer	0.000149	0.000994	CcSEcCtD
Tenoxicam—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000149	0.000994	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000148	0.000991	CcSEcCtD
Tenoxicam—Fatigue—Methotrexate—urinary bladder cancer	0.000148	0.00099	CcSEcCtD
Tenoxicam—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000146	0.000975	CcSEcCtD
Tenoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000146	0.00406	CbGpPWpGaD
Tenoxicam—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000145	0.000973	CcSEcCtD
Tenoxicam—Skin disorder—Doxorubicin—urinary bladder cancer	0.000144	0.000966	CcSEcCtD
Tenoxicam—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000144	0.00401	CbGpPWpGaD
Tenoxicam—Dyspnoea—Epirubicin—urinary bladder cancer	0.000143	0.000958	CcSEcCtD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000143	0.00399	CbGpPWpGaD
Tenoxicam—Anorexia—Doxorubicin—urinary bladder cancer	0.000142	0.000948	CcSEcCtD
Tenoxicam—Dyspepsia—Epirubicin—urinary bladder cancer	0.000141	0.000946	CcSEcCtD
Tenoxicam—Decreased appetite—Epirubicin—urinary bladder cancer	0.00014	0.000934	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000139	0.000928	CcSEcCtD
Tenoxicam—Fatigue—Epirubicin—urinary bladder cancer	0.000138	0.000926	CcSEcCtD
Tenoxicam—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000137	0.00383	CbGpPWpGaD
Tenoxicam—Constipation—Epirubicin—urinary bladder cancer	0.000137	0.000919	CcSEcCtD
Tenoxicam—Urticaria—Methotrexate—urinary bladder cancer	0.000136	0.000912	CcSEcCtD
Tenoxicam—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000132	0.000886	CcSEcCtD
Tenoxicam—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000131	0.000875	CcSEcCtD
Tenoxicam—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000129	0.000864	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000128	0.000858	CcSEcCtD
Tenoxicam—Fatigue—Doxorubicin—urinary bladder cancer	0.000128	0.000857	CcSEcCtD
Tenoxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000128	0.00357	CbGpPWpGaD
Tenoxicam—Urticaria—Epirubicin—urinary bladder cancer	0.000128	0.000854	CcSEcCtD
Tenoxicam—Constipation—Doxorubicin—urinary bladder cancer	0.000127	0.00085	CcSEcCtD
Tenoxicam—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000127	0.00353	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000126	0.000846	CcSEcCtD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000125	0.00348	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000124	0.00347	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000124	0.00346	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000123	0.00344	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000123	0.00344	CbGpPWpGaD
Tenoxicam—Asthenia—Methotrexate—urinary bladder cancer	0.000123	0.000824	CcSEcCtD
Tenoxicam—Pruritus—Methotrexate—urinary bladder cancer	0.000121	0.000812	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000119	0.00331	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000118	0.000792	CcSEcCtD
Tenoxicam—Urticaria—Doxorubicin—urinary bladder cancer	0.000118	0.00079	CcSEcCtD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000118	0.00328	CbGpPWpGaD
Tenoxicam—Diarrhoea—Methotrexate—urinary bladder cancer	0.000117	0.000786	CcSEcCtD
Tenoxicam—Asthenia—Epirubicin—urinary bladder cancer	0.000115	0.000771	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000115	0.00321	CbGpPWpGaD
Tenoxicam—Pruritus—Epirubicin—urinary bladder cancer	0.000114	0.00076	CcSEcCtD
Tenoxicam—Dizziness—Methotrexate—urinary bladder cancer	0.000113	0.000759	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000113	0.00315	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000112	0.00314	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000111	0.00309	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.00011	0.00306	CbGpPWpGaD
Tenoxicam—Diarrhoea—Epirubicin—urinary bladder cancer	0.00011	0.000735	CcSEcCtD
Tenoxicam—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000109	0.000733	CcSEcCtD
Tenoxicam—Vomiting—Methotrexate—urinary bladder cancer	0.000109	0.00073	CcSEcCtD
Tenoxicam—Rash—Methotrexate—urinary bladder cancer	0.000108	0.000724	CcSEcCtD
Tenoxicam—Dermatitis—Methotrexate—urinary bladder cancer	0.000108	0.000723	CcSEcCtD
Tenoxicam—Headache—Methotrexate—urinary bladder cancer	0.000107	0.000719	CcSEcCtD
Tenoxicam—Asthenia—Doxorubicin—urinary bladder cancer	0.000107	0.000713	CcSEcCtD
Tenoxicam—Dizziness—Epirubicin—urinary bladder cancer	0.000106	0.000711	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000106	0.00295	CbGpPWpGaD
Tenoxicam—Pruritus—Doxorubicin—urinary bladder cancer	0.000105	0.000703	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000102	0.00286	CbGpPWpGaD
Tenoxicam—Vomiting—Epirubicin—urinary bladder cancer	0.000102	0.000683	CcSEcCtD
Tenoxicam—Nausea—Methotrexate—urinary bladder cancer	0.000102	0.000682	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000102	0.00284	CbGpPWpGaD
Tenoxicam—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000102	0.00068	CcSEcCtD
Tenoxicam—Rash—Epirubicin—urinary bladder cancer	0.000101	0.000678	CcSEcCtD
Tenoxicam—Dermatitis—Epirubicin—urinary bladder cancer	0.000101	0.000677	CcSEcCtD
Tenoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000101	0.00281	CbGpPWpGaD
Tenoxicam—Headache—Epirubicin—urinary bladder cancer	0.000101	0.000673	CcSEcCtD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.99e-05	0.00279	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	9.84e-05	0.00275	CbGpPWpGaD
Tenoxicam—Dizziness—Doxorubicin—urinary bladder cancer	9.82e-05	0.000657	CcSEcCtD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.8e-05	0.00273	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	9.63e-05	0.00269	CbGpPWpGaD
Tenoxicam—Nausea—Epirubicin—urinary bladder cancer	9.53e-05	0.000638	CcSEcCtD
Tenoxicam—Vomiting—Doxorubicin—urinary bladder cancer	9.44e-05	0.000632	CcSEcCtD
Tenoxicam—Rash—Doxorubicin—urinary bladder cancer	9.36e-05	0.000627	CcSEcCtD
Tenoxicam—Dermatitis—Doxorubicin—urinary bladder cancer	9.36e-05	0.000626	CcSEcCtD
Tenoxicam—Headache—Doxorubicin—urinary bladder cancer	9.3e-05	0.000623	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	9.17e-05	0.00256	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.1e-05	0.00254	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	8.99e-05	0.00251	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	8.97e-05	0.0025	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	8.95e-05	0.00249	CbGpPWpGaD
Tenoxicam—Nausea—Doxorubicin—urinary bladder cancer	8.82e-05	0.000591	CcSEcCtD
Tenoxicam—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	8.72e-05	0.00243	CbGpPWpGaD
Tenoxicam—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	8.58e-05	0.00239	CbGpPWpGaD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	8.41e-05	0.00235	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.4e-05	0.00234	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.95e-05	0.00222	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.8e-05	0.00218	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	7.78e-05	0.00217	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.73e-05	0.00216	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	7.58e-05	0.00211	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	7.33e-05	0.00205	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	7.06e-05	0.00197	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	7.04e-05	0.00196	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	6.98e-05	0.00195	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.92e-05	0.00193	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.87e-05	0.00192	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTO2—urinary bladder cancer	6.68e-05	0.00186	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NAT1—urinary bladder cancer	6.68e-05	0.00186	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.57e-05	0.00183	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	6.49e-05	0.00181	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GSTO2—urinary bladder cancer	6.33e-05	0.00177	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	6.2e-05	0.00173	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.11e-05	0.0017	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	6.11e-05	0.0017	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.09e-05	0.0017	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	6.08e-05	0.0017	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.06e-05	0.00169	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	6.05e-05	0.00169	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.96e-05	0.00166	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	5.93e-05	0.00165	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	5.78e-05	0.00161	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	5.62e-05	0.00157	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	5.61e-05	0.00156	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	5.59e-05	0.00156	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	5.56e-05	0.00155	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	5.5e-05	0.00153	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.48e-05	0.00153	CbGpPWpGaD
Tenoxicam—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.46e-05	0.00152	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.31e-05	0.00148	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTO2—urinary bladder cancer	5.3e-05	0.00148	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NAT1—urinary bladder cancer	5.3e-05	0.00148	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.24e-05	0.00146	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.21e-05	0.00145	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	5.19e-05	0.00145	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PRSS3—urinary bladder cancer	5.06e-05	0.00141	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SLC19A1—urinary bladder cancer	4.92e-05	0.00137	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	4.85e-05	0.00135	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PRSS3—urinary bladder cancer	4.8e-05	0.00134	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	4.78e-05	0.00133	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.63e-05	0.00129	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HDAC4—urinary bladder cancer	4.58e-05	0.00128	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	4.53e-05	0.00126	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.45e-05	0.00124	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	4.37e-05	0.00122	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	4.32e-05	0.0012	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	4.12e-05	0.00115	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.06e-05	0.00113	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—TYMP—urinary bladder cancer	4.05e-05	0.00113	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PRSS3—urinary bladder cancer	4.02e-05	0.00112	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.93e-05	0.0011	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.93e-05	0.0011	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.89e-05	0.00108	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	3.8e-05	0.00106	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.8e-05	0.00106	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.79e-05	0.00106	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	3.7e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NAT2—urinary bladder cancer	3.66e-05	0.00102	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—LIG1—urinary bladder cancer	3.64e-05	0.00101	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.62e-05	0.00101	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.52e-05	0.000981	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	3.51e-05	0.000979	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NAT1—urinary bladder cancer	3.51e-05	0.000979	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.45e-05	0.000963	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.22e-05	0.000898	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.21e-05	0.000896	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	3.21e-05	0.000896	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.16e-05	0.000881	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.15e-05	0.000879	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.08e-05	0.00086	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.08e-05	0.00086	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.94e-05	0.000819	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—HPGDS—urinary bladder cancer	2.93e-05	0.000816	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ENO2—urinary bladder cancer	2.93e-05	0.000816	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.91e-05	0.000812	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.91e-05	0.000811	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.9e-05	0.00081	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	2.89e-05	0.000806	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTT1—urinary bladder cancer	2.84e-05	0.000791	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.79e-05	0.000779	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ENO2—urinary bladder cancer	2.77e-05	0.000773	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	2.73e-05	0.000761	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	2.66e-05	0.000742	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RBX1—urinary bladder cancer	2.63e-05	0.000733	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.59e-05	0.000722	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.51e-05	0.000699	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.36e-05	0.000658	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—JAG1—urinary bladder cancer	2.35e-05	0.000656	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.32e-05	0.000648	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.32e-05	0.000648	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.31e-05	0.000644	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.29e-05	0.000638	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.25e-05	0.000628	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.22e-05	0.000619	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.13e-05	0.000595	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.13e-05	0.000593	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.04e-05	0.00057	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2e-05	0.000556	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.97e-05	0.000548	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.92e-05	0.000537	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.9e-05	0.000531	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.87e-05	0.000522	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.83e-05	0.00051	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.81e-05	0.000504	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.81e-05	0.000504	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.73e-05	0.000483	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NCOR1—urinary bladder cancer	1.71e-05	0.000478	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.7e-05	0.000474	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.66e-05	0.000463	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERCC2—urinary bladder cancer	1.61e-05	0.000449	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.6e-05	0.000445	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.58e-05	0.000442	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.56e-05	0.000435	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.54e-05	0.000429	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.54e-05	0.000429	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.53e-05	0.000426	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MTHFR—urinary bladder cancer	1.51e-05	0.000422	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.51e-05	0.000421	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TERT—urinary bladder cancer	1.51e-05	0.000421	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.49e-05	0.000416	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.47e-05	0.00041	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.45e-05	0.000405	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.43e-05	0.0004	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.43e-05	0.0004	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FGFR3—urinary bladder cancer	1.39e-05	0.000386	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.37e-05	0.000383	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.35e-05	0.000376	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.3e-05	0.000361	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.27e-05	0.000354	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	0.000347	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.24e-05	0.000346	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.2e-05	0.000335	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CREBBP—urinary bladder cancer	1.18e-05	0.000329	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—RHOA—urinary bladder cancer	1.07e-05	0.000298	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.05e-05	0.000293	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.03e-05	0.000288	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.03e-05	0.000287	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	0.000284	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1e-05	0.000279	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CREBBP—urinary bladder cancer	9.88e-06	0.000275	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB2—urinary bladder cancer	9.88e-06	0.000275	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TYMS—urinary bladder cancer	9.61e-06	0.000268	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	9.5e-06	0.000265	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	9.5e-06	0.000265	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GPX1—urinary bladder cancer	9.1e-06	0.000254	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	8.93e-06	0.000249	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTEN—urinary bladder cancer	8.88e-06	0.000248	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—EP300—urinary bladder cancer	8.47e-06	0.000236	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1A—urinary bladder cancer	8.44e-06	0.000235	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PTEN—urinary bladder cancer	8.42e-06	0.000235	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	8.4e-06	0.000234	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EP300—urinary bladder cancer	8.03e-06	0.000224	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SRC—urinary bladder cancer	7.81e-06	0.000218	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PTEN—urinary bladder cancer	7.05e-06	0.000197	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MYC—urinary bladder cancer	7e-06	0.000195	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EGFR—urinary bladder cancer	6.85e-06	0.000191	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PPARG—urinary bladder cancer	6.81e-06	0.00019	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—EP300—urinary bladder cancer	6.73e-06	0.000188	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	6.54e-06	0.000182	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KRAS—urinary bladder cancer	6.47e-06	0.00018	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HRAS—urinary bladder cancer	5.5e-06	0.000153	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	5.36e-06	0.000149	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.67e-06	0.00013	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.45e-06	0.000124	CbGpPWpGaD
